Fig 2.
Weighted cumulative incidence curves of severe chronic obstructive pulmonary disease (COPD) exacerbations in glucagon-like peptide-1 receptor agonist (GLP-1 RA) versus sulfonylurea cohort
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.